ABCELLERA BIOLOGICS
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
ABCELLERA BIOLOGICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2012-01-01
Status:
Active
Contact:
(604) 559-9005
Total Funding:
371.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Amazon IPv6 Google Apps For Business Microsoft Azure DNS
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-13 | Tetragenetics | Tetragenetics acquired by AbCellera Biologics | N/A |
| 2020-11-18 | Trianni | Trianni acquired by AbCellera Biologics | 90 M USD |
| 2020-08-20 | Dualogics - OrthoMab | Dualogics - OrthoMab acquired by AbCellera Biologics | N/A |
| 2018-08-01 | Lineage Biosciences | Lineage Biosciences acquired by AbCellera Biologics | N/A |
Investors List
Eli Lilly
Eli Lilly investment in Series B - AbCellera Biologics
Presight Capital
Presight Capital investment in Series B - AbCellera Biologics
Founders Fund
Founders Fund investment in Series B - AbCellera Biologics
OrbiMed
OrbiMed investment in Series B - AbCellera Biologics
DCVC
DCVC investment in Series B - AbCellera Biologics
Peter Thiel
Peter Thiel investment in Series B - AbCellera Biologics
Viking Global Investors
Viking Global Investors investment in Series B - AbCellera Biologics
University of Minnesota
University of Minnesota investment in Series B - AbCellera Biologics
Government of Canada
Government of Canada investment in Grant - AbCellera Biologics
Founders Fund
Founders Fund investment in Series A - AbCellera Biologics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-30 | Invetx | AbCellera Biologics investment in Series A - Invetx | 10.25 M USD |
| 2020-02-24 | Invetx | AbCellera Biologics investment in Series A - Invetx | 15 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-13 | AbCellera Appoints Neil Berkley as Chief Business Officer |